Table 3.
Trends in age- and sex-standardized BZRA prescription rates among patients who received <3 BZRA prescriptions in 1 year between 2000 and 2019.
| Group | 2000 N = 7,209 |
2019 N = 24,962 |
Summary | Trend 1 | Trend 2 | ||
|---|---|---|---|---|---|---|---|
| % | % | AAPC | Years | APC | Years | APC | |
| Prescriptions | |||||||
| BZRA < 3 | 65.1 | 57.6 | 0.6 (−0.1; 1.3) | 2000–2019 | 0.6 (−0.1; 1.3) | ||
| Overall 18–44 | 18.1 | 16.3 | 1.4 (0.6; 2.2) | 2000–2012 | −0.4 (−1.3; 0.6) | 2012–2019 | 4.4 (2.6; 6.1) |
| Overall 45–64 | 24.1 | 21.7 | 0.4 (−0.1; 0.9) | 2000–2012 | –0.9 (–1.5; –0.3) | 2012–2019 | 2.6 (1.4; 3.7) |
| Overall 65+ | 22.9 | 19.6 | 0.5 (−0.2; 1.2) | 2000–2016 | −0.3 (−0.7; 0.1) | 2016–2019 | 4.7 (0.2; 9.3) |
| Males | 23.9 | 21.9 | 0.9 (0.2; 1.6) | 2000–2019 | 0.9 (0.2; 1.6) | ||
| Males 18–44 | 7.3 | 6.4 | 1.7 (0.8; 2.6) | 2000–2010 | −0.1 (−1.6; 1.4) | 2010–2019 | 3.7 (2.3; 5.1) |
| Males 45–64 | 9.2 | 8.6 | 0.8 (0.2; 1.4) | 2000–2012 | −0.6 (−1.3; 0.1) | 2012–2019 | 3.3 (1.9; 4.6) |
| Males 65+ | 7.3 | 6.9 | 0.5 (0.1; 1.0) | 2000–2019 | 0.5 (0.1; 1.0) | ||
| Females | 41.2 | 35.7 | 0.4 (−0.4; 1.3) | 2000–2019 | 0.4 (−0.4; 1.3) | ||
| Females 18–44 | 10.8 | 9.9 | 1.0 (0.1; 1.9) | 2000–2012 | −0.9 (−2.0; 0.2) | 2012–2019 | 4.3 (2.3; 6.3) |
| Females 45–64 | 14.9 | 13.1 | 0.1 (−0.5; 0.7) | 2000–2012 | –1.0 (–1.7; –0.3) | 2012–2019 | 2.0 (0.7; 3.3) |
| Females 65+ | 15.5 | 12.7 | 0.4 (−0.3; 1.2) | 2000–2016 | −0.3 (−0.8; 0.1) | 2016–2019 | 4.8 (0.0; 9.8) |
AAPC, average annual percentage change; APC, average percentage change; statistically significant trends (95% CI) in bold.